Delivery Order SPE2DP20D0002-SPE2DP23F2845

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2023 through April 25, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $293,647.86 firm fixed price delivery order contract to provide Adenovirus Type 4 from January 18, 2022 through January 25, 2022. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $610,787.52 firm fixed price delivery order contract to provide Adenovirus Type 4 from June 20, 2023 through June 27, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4 from January 18, 2023 through January 24, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance starting on May 17, 2023 through May 23, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from their location in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2023 through April 25, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from its place of performance in Parsippany, New Jersey.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $440,471.79 firm fixed price delivery order contract to provide adenovirus type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., will perform the work in Parsippany, New Jersey from January 18, 2022 through January 25, 2022.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded Teva Pharmaceuticals USA, Inc. a $763,484.40 firm fixed price delivery order contract to provide adenovirus type 4 with a period of performance starting on May 17, 2023 through May 23, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from its location in Parsippany, New Jersey. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 from January 18, 2023 through January 24, 2023. Teva Pharmaceuticals USA, Inc. will perform all work as the prime contractor at their location in Parsippany, New Jersey.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4. The place of performance for this January 18-24, 2023 contract is Teva Pharmaceuticals' facility located in Parsippany, New Jersey.</p>